Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

2.59
Delayed Data
As of 4:00pm ET
 -0.11 / -4.07%
Today’s Change
2.20
Today|||52-Week Range
11.75
-16.18%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close2.70
Today’s open2.76
Day’s range2.51 - 2.77
Volume62,827
Average volume (3 months)124,982
Market cap$65.8M
Dividend yield--
Data as of 4:00pm ET, 02/09/2016

Growth & Valuation

Earnings growth (last year)+59.46%
Earnings growth (this year)+67.79%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.97%
P/E ratioNM
Price/Sales8,705.73
Price/Book1.08

Competitors

 Today’s
change
Today’s
% change
REPHRecro Pharma Inc-0.46-6.49%
RNNRexahn Pharmaceutica...+0.01+2.68%
AKAOAchaogen Inc-0.00-0.15%
NVLSNivalis Therapeutics...+0.04+0.90%
Data as of 4:00pm ET, 02/09/2016

Financials

Next reporting dateMarch 21, 2016
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$4.0K
Annual profit (last year)-$41.8M
Net profit margin-1,046,100.00%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer, Treasurer &
Senior VP
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers